Leonardo Michele Fabbri - University of Gothenburg, Sweden

Leonardo Michele Fabbri
Professor, gäst
leonardo.michele.fabbri@gu.se

Postal Address: Su sahlgrenska, 41345 Göteborg
Visiting Address: Vita stråket su , 41345 Göteborg

Department of Internal Medicine at Institute of Medicine (More Information)
SU Sahlgrenska
413 45 Göteborg
0313421000
Fax: +46 317863101
Visiting Address: Vita stråket SU , 413 45 Göteborg

About Leonardo Michele Fabbri

CV

Research areas

Medical and Health Sciences
- Clinical Medicine
  - Respiratory Medicine and Allergy

Latest publications

Asthma progression and mortality: the role of inhaled corticosteroids
P. O'Byrne, Leonardo M. Fabbri, I. D. Pavord, A. Papi, S. Petruzzelli et al.
European Respiratory Journal, Journal article 2019
Journal article

Read the full text
on a web page

Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA
D. Singh, Leonardo M. Fabbri, S. Vezzoli, S. Petruzzelli, A. Papi
International journal of chronic obstructive pulmonary disease, Journal article 2019
Journal article

Read the full text
on a web page

Impact of smoking status and concomitant medications on the effect of high-dose N-acetylcysteine on chronic obstructive pulmonary disease exacerbations: A post-hoc analysis of the PANTHEON study
A. Papi, J. P. Zheng, G. J. Criner, Leonardo M. Fabbri, P. M. A. Calverley
Respiratory Medicine, Journal article 2019
Journal article

Read the full text
on a web page

Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal
Lowie E G W Vanfleteren, Leonardo M. Fabbri, A. Papi, S. Petruzzelli, B. Celli
International Journal of Chronic Obstructive Pulmonary Disease, Journal article 2018
Journal article

Read the full text
on a web page

2019

Asthma progression and mortality: the role of inhaled corticosteroids
P. O'Byrne, Leonardo M. Fabbri, I. D. Pavord, A. Papi, S. Petruzzelli et al.
European Respiratory Journal, Journal article 2019
Journal article

Read the full text
on a web page

Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA
D. Singh, Leonardo M. Fabbri, S. Vezzoli, S. Petruzzelli, A. Papi
International journal of chronic obstructive pulmonary disease, Journal article 2019
Journal article

Read the full text
on a web page

Impact of smoking status and concomitant medications on the effect of high-dose N-acetylcysteine on chronic obstructive pulmonary disease exacerbations: A post-hoc analysis of the PANTHEON study
A. Papi, J. P. Zheng, G. J. Criner, Leonardo M. Fabbri, P. M. A. Calverley
Respiratory Medicine, Journal article 2019
Journal article

Read the full text
on a web page

2018

Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal
Lowie E G W Vanfleteren, Leonardo M. Fabbri, A. Papi, S. Petruzzelli, B. Celli
International Journal of Chronic Obstructive Pulmonary Disease, Journal article 2018
Journal article

Read the full text
on a web page

Showing 1 - 4 of 4